Results 261 to 270 of about 1,859,513 (388)

An Expert Consensus Statement on Biomarkers of Aging for Use in Intervention Studies. [PDF]

J Gerontol A Biol Sci Med Sci
Perri G, French C, Agostinis-Sobrinho C, Anand A, Antarianto RD, Arai Y, Baur JA, Cauli O, Clivaz-Duc M, Colloca G, Demetriades C, de Lucia C, Di Gessa G, Diniz BS, Dotchin CL, Eaglestone G, Elliott BT, Espeland MA, Ferrucci L, Fisher J, Grammatopoulos DK, Hardiany NS, Hassan-Smith Z, Hastings WJ, Jain S, Joshi PK, Katsila T, Kemp GJ, Khaiyat OA, Lamming DW, Gallegos JL, Madeo F, Maier AB, Martin-Ruiz C, Martins IJ, Mathers JC, Mattin LR, Merchant RA, Moskalev A, Neytchev O, Ni Lochlainn M, Owen CM, Phillips SM, Pratt J, Prokopidis K, Rattray NJW, Rúa-Alonso M, Schomburg L, Scott D, Shyam S, Sillanpää E, Tan MMC, Teh R, Tobin SW, Vila-Chã CJ, Vorluni L, Weber D, Welch A, Wilson D, Wilson T, Zhao T, Philippou E, Korolchuk VI, Shannon OM.   +63 more
europepmc   +1 more source

CSF and blood biomarkers for the diagnosis of Alzheimer's disease: a systematic review and meta-analysis

Lancet Neurology, 2016
B. Olsson, Ronald Lautner, U. Andreasson, A. Öhrfelt, E. Portelius, M. Bjerke, M. Hölttä, Christoffer Rosén, C. Olsson, G. Strobel, Elizabeth Wu, K. Dakin, Max Petzold, K. Blennow, H. Zetterberg   +14 more
semanticscholar   +1 more source

Enabling precision medicine with biomarkers of response to treatment in atopic dermatitis: where are we now? A narrative review. [PDF]

Front Med (Lausanne)
Chiricozzi A, Levi A, Palladino C, Girolomoni G.   +3 more
europepmc   +1 more source

The Role of Biomarkers in Detecting Early Changes Relating to Exposure to Occupational Carcinogens [PDF]

, 1996
Judith Shaham, Joseph Ribak
openalex   +1 more source

Calcium modulating ligand confers risk for Parkinson's disease and impacts lysosomes

Annals of Clinical and Translational Neurology, EarlyView.
Abstract Objective Several genetic loci known to confer risk for Parkinson's disease (PD) function in lysosomal pathways. We systematically screened common variants linked to PD risk by genome‐wide association studies (GWAS) for impact on cerebrospinal fluid (CSF) proteins reflecting lysosomal function.
Hanwen Zhang, Daniel Kargilis, Thomas Tropea, John Robinson, Junchao Shen, Eliza M. Brody, Ann Brinkmalm, Simon Sjödin, Adama J. Berndt, Marc Carceles‐Cordon, EunRan Suh, Vivianna M. Van Deerlin, Kaj Blennow, Daniel Weintraub, Edward B. Lee, Henrik Zetterberg, Alice S. Chen‐Plotkin   +16 more
wiley   +1 more source

The Clinical Utility of Biomarkers in Diagnosing Major Depressive Disorder in Adults: A Systematic Review of Literature From 2013 to 2023. [PDF]

Psychiatry Investig
Ang SH, Ho RC, McIntyre RS, Zhang Z, Chang SK, Teopiz KM, Ho CS.   +6 more
europepmc   +1 more source

Genotoxic Effects in Workers Exposed to Benzene: With Special Reference to Exposure Biomarkers and Confounding Factors.

, 1997
Ana Bogadi‐Šare, Vlatka Brumen, Rajka Turk, Višnja Karačić, Marija Zavalić   +4 more
openalex   +2 more sources

Variability in biomarkers of different saline basins in China [PDF]

, 1997
R. Wang, Jinyuan Fu
openalex   +1 more source

Biomarkers in cholangiocarcinoma [PDF]

Clinical Liver Disease, 2014
openaire   +2 more sources

Relationship of cognitive decline with glucocerebrosidase activity and amyloid‐beta 42 in DLB and PD

Annals of Clinical and Translational Neurology, EarlyView.
Abstract Objective Dementia with Lewy bodies (DLB) and Parkinson's disease (PD) share clinical, pathological, and genetic risk factors, including GBA1 and APOEε4 mutations. Biomarkers associated with the pathways of these mutations, such as glucocerebrosidase enzyme (GCase) activity and amyloid‐beta 42 (Aβ42) levels, may hold potential as predictive ...
Maria Camila Gonzalez, Linn Oftedal, Johannes Lange, Diego Alejandro Tovar‐Rios, Ole‐Bjørn Tysnes, Claire Paquet, Marta Marquié, Mercè Boada, Daniel Alcolea, Konrad Rejdak, Ewa Papuc, Jakub Hort, Cristian Falup‐Pecurariu, Dag Aarsland, Guido Alves, Jodi Maple‐Grødem   +15 more
wiley   +1 more source